10th Circ. Backs Wyeth, Schwarz Win in Generic Reglan Suit

Law360, New York (August 28, 2013, 4:34 PM EDT) -- The Tenth Circuit on Wednesday affirmed that an Oklahoma couple cannot hold Wyeth Inc. and Schwarz Pharma Inc. liable for failure to warn about purported neurological side effects from generic versions of their brand-name heartburn drug Reglan.

A unanimous appeals panel upheld an Oklahoma federal court’s 2009 dismissal of Susan and Steve Schrock’s claims against Wyeth and Schwarz, saying that while the state Supreme Court has not weighed in on the matter, all evidence suggests Oklahoma tort law would not require brand-name drug makers to warn...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.